Delivery Order SPE2DB24D2205-SPE2DB25FEFMM
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 28, 2025, for $33.4K to supply Biktarvy 50-200-25 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with performance completion scheduled for July 29, 2025, and work to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $34,787.81 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 25, 2025. The contract is performed from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $62,597.51 by the Defense Logistics Agency (DLA) on August 11, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This firm fixed-price, non-set-aside contract is scheduled for completion by August 12, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a relatively small transaction within AmerisourceBergen's broader federal...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency (DLA) valued at $1,548.16 for Biktarvy 50-200-25 mg tablets in quantities of 30 units. This contract is classified as a firm fixed price delivery order with an ultimate completion date of July 25, 2025, and no set-aside designation. The award serves the federal medical supply chain supporting military and veteran healthcare systems through...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $31,715.77 by the Defense Logistics Agency on July 22, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed price contract carries an ultimate completion date of July 23, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 7, 2025, by the Defense Logistics Agency for $50,225.55 to supply Biktarvy 50-200-25 mg tablets in quantities of 30. This firm fixed-price delivery order, which is not set-aside designated, is expected to be completed by August 8, 2025, and will be performed at the contractor's Conshohocken facility. The award represents a continuation of...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 11, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count unit dose packages) valued at $28,563.74. This competitively awarded, firm fixed-price delivery order is funded by the Defense Logistics Agency (DLA), a defense agency responsible for supplying pharmaceuticals and medical materiel to military health systems. The contract is...
- The Defense Logistics Agency awarded a $35,074.07 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. The contract is non-set-aside and competitively awarded, with an ultimate completion date of August 13, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $17,897.96 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with no set-aside designation, competitively awarded and scheduled for completion by July 25, 2025. The award represents a pharmaceutical supply order under AmerisourceBergen's larger contract vehicle with DLA Troop Support Medical, which serves as the primary mechanism for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $80,409.74 to supply Biktarvy 50-200-25 mg tablets (30-count bottles) under a firm fixed-price contract with an ultimate completion date of August 4, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFMMDelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency valued at $51,148.62 for Biktarvy 50-200-25 mg tablets (30-count units). The contract is a firm fixed price delivery order with a completion date of July 29, 2025, and was awarded on July 28, 2025. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The delivery order carries no set-aside designation, indicating it was awarded through open competition. AmerisourceBergen's federal contract portfolio demonstrates extensive experience fulfilling critical pharmaceutical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company supplies a diverse range of medical commodities, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This particular award for Biktarvy, an antiretroviral medication used in HIV treatment, reflects the company's role as a critical vendor within the federal medical supply chain serving military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $51.1k | 7/28/25 |